THE TREND
(Boursier.com) — Very calm session confirmed this Friday with a CAC40 which gained 0.2% to 7,293 points in low trading volumes while Wall Street, on break yesterday for Thanksgiving, only reopened today for a short session which will end at 7 p.m. French time.
This “Black Friday”, usually marked by a certain excitement on the American market around consumer values, is a little more depressed than usual, while the latest financial forecasts from major US retailers for the holiday season end of the year were generally uneventful.
Today’s rankings on the Paris stock market reveal little upward or downward variation among the CAC40 values. A CAC40 which is now less than 300 points from its April highs. Concerns over rising respiratory illnesses in China have led to some minor profit-taking in the luxury sector.
RISING VALUES
* Lectra jumped 5% to 29.3 euros. The title of the group specializing in software and automatic cutting systems for leather or textiles is boosted by a rating from BNP Paribas Exane which raised its recommendation on the value to ‘outperform’ by targeting 35 euros.
* TotalEnergies gained 0.5% to 63.1 euros and returned close to its highs. The barrel of Brent is gaining ground again, back to 82 dollars.
* Vivendi gained 1.2% to 8.82 euros. Oddo BHF adjusted the slider from 13.5 to 13 euros (‘outperform’).
* Michelin ended slightly up 0.2% at 29.9 euros. Barclays downgraded Michelin to ‘underweight’ but with a price target of 34 euros.
FALLING VALUES
* Among the rarest drops today on the CAC40, LVMH yields 0.7% and Hermes 0.4%. Chinese health authorities have not detected anything unusual or new pathogens in the country. This is Beijing’s response as the number of cases of respiratory diseases and pneumonia has increased among children, the World Health Organization (WHO) said on Thursday, which said it had received the requested data earlier. As required, Chinese authorities responded within 24 hours to the WHO’s request for clarification on Wednesday after several groups, including the Emerging Disease Surveillance Program, reported outbreaks of undiagnosed pneumonia in children in northern China. They attributed this increase to the lifting of restrictions put in place to combat the COVID-19 pandemic and to the circulation of known pathogens such as influenza or the virus that causes COVID-19…
* Orpea logically continues its 20% drop to 0.24 euros while the subscription period for the first capital increase of approximately 3.9 billion euros is open until next Monday, at a price of 0.0601 euros per new action. This bailout should mainly be done by offsetting debts. The clearance capital increase is in fact the subject of subscription commitments as a guarantee by Orpea’s unsecured creditors by way of offsetting debts up to the portion of the issue which would not have not been subscribed to by the holders of DPS. The new actions are due to arrive on December 4.